Am fost foarte mândru de eforturile industriei noastre de a uni și a pune interesul pacienților absolut pe primul loc în timpul acestei crize

5 October 2020

Interviu cu Adrian van den Hoven, director general Medicines for Europe  […]

IGBA: Global Roadmap for Tailored Clinical Biosimilar Development: Instrumental for Sustainable Access to Biologics

24 September 2020

Joint press statement of European Pharmaceutical industry associations

17 September 2020

Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies

17 September 2020

Practical measures are paramount for robust medicines manufacturing

9 September 2020

Interview: Medicines for Europe Reports on EU Biosimilar Success

27 July 2020

The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven, […]

Christoph Stoller and Adrian van den Hoven interviewed by PharmaBoardroom

17 July 2020

In the wake of the publication of Medicines for Europe’s Lessons […]

COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy

9 July 2020

Urgent call for a structured industry-EU dialogue on reform The […]

IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe

30 June 2020

Good biosimilar medicine policies balance the benefits of multi-source competition, […]

EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from Covid19

4 June 2020